Molecular and Cellular Biochemistry

, Volume 166, Issue 1–2, pp 169–175 | Cite as

Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats

  • P. Suresh Babu
  • K. Srinivasan
Article

Abstract

Streptozotocin-induced diabetic rats were maintained on 0.5% curcumin containing diet for 8 weeks. Blood cholesterol was lowered significantly by dietary curcumin in these diabetic animals. Cholesterol decrease was exclusively from LDL-VLDL fraction. Significant decrease in blood triglyceride and phospholipids was also brought about by dietary curcumin in diabetic rats. In a parallel study, wherein diabetic animals were maintained on a high cholesterol diet, the extents of hypercholesterolemia and phospholipidemia were still higher compared to those maintained on control diet. Curcumin exhibited lowering of cholesterol and phospholipid in these animals also. Liver cholesterol, triglyceride and phospholipid contents were elevated under diabetic conditions. Dietary curcumin showed a distinct tendency to counter these changes in lipid fractions of liver. This effect of curcumin was also seen in diabetic animals maintained on high cholesterol diet. Dietary curcumin also showed significant countering of renal cholesterol and triglycerides elevated in diabetic rats.

In order to understand the mechanism of hypocholesterolemic action of dietary curcumin, activities of hepatic cholesterol-7a-hydroxylase and HMG CoA reductase were measured. Hepatic cholesterol-7a-hydroxylase activity was markedly higher in curcumin fed diabetic animals suggesting a higher rate of cholesterol catabolism. (Mol Cell Biochem 166: 169-175, 1997)

curcumin diabetes mellitus cholesterol metabolism hypolipidemic action 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Schonfeld G: Diabetes, lipoproteins and atherosclerosis. 34: 45–50, 1985Google Scholar
  2. 2.
    Steiner G: Diabetes, atherosclerosis and metabolic links. Drugs 36: 22–26, 1988Google Scholar
  3. 3.
    Stamler J: Established relationship among diet, serum cholesterol and coronary heart diseases. Acta Med Scand 207: 433–446, 1980Google Scholar
  4. 4.
    Haffner SM: Compositional changes in lipoproteins of subjects with NIDDM. J Lab Clin Med 118: 109–110, 1991Google Scholar
  5. 5.
    American Diabetic Association. Nutritional recommendations and principles for individuals with diabetes mellitus. Diabetes Care 10: 126–132, 1986Google Scholar
  6. 6.
    Nadkarni AK: Indian Materia Medica, Popular Prakashan Pvt. Ltd., Bombay, India. Vol. 1, 3rd edn. 1976: pp 63, 475, 835Google Scholar
  7. 7.
    Carson JF: Chemistry and biological properties of onion and garlic. Food Rev Internat 3: 71–103, 1987Google Scholar
  8. 8.
    Subbarao D, Chandrasekhara N, Satyanarayana MN, Srinivasan M: Effect of curcumin on serum and liver cholesterol levels in the rat. J Nutr 100: 1307–1315, 1970Google Scholar
  9. 9.
    Sharma RD: An evaluation of hypocholesterolemic factor of fenugreek seeds. Nutr Rep Internat 33: 669–678, 1986Google Scholar
  10. 10.
    Kawada T, Hagihara K, Iwai K: Effect of capsaicin on lipid metabolism in rats fed with high fat diet. J Nutr 116: 1272–1278, 1986Google Scholar
  11. 11.
    Huggelt ASG, Nixon DN: Use of glucose oxidase, peroxidase and o-dianisidine in the determination of blood and urinary glucose. Lancet: 368–370, 1957Google Scholar
  12. 12.
    Folch J, Lees M, Sloane-Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497–509, 1957Google Scholar
  13. 13.
    Searcy RL, Bergquist LM: A new color reaction for quantitation of serum cholesterol. Clin Chim Acta 5: 192–197, 1960Google Scholar
  14. 14.
    Warnick GR, Albers JJ: A comprehensive evaluation of heparin-manganese procedure for estimating HDL-cholesterol. J Lipid Res 19: 65–76, 1978Google Scholar
  15. 15.
    Fletcher MJ: A colorimetric method for estimating serum triglycerides. Clin Chim Acta 22: 393–397, 1968Google Scholar
  16. 16.
    Charles J, Stewart M: Colorimetric determination of phospholipids with ammonium ferrothiocynate. Anal Biochem 104: 10–14, 1980Google Scholar
  17. 17.
    Mitropoules KA, Balasubramaniam S: Cholesterol-7a-hydroxylase in rat liver microsomal preparations. Biochem J 128: 1–9, 1972Google Scholar
  18. 18.
    Hassan AS, Hackley JJ, Jeffery EH: Role of glutathione in the regulation of hepatic cholesterol-7a-hydroxylase, the rate limiting enzyme of bile acid synthesis. Steroids 44: 373–380, 1984Google Scholar
  19. 19.
    Srinivasan K, Sambaiah K: The effect of spices on cholesterol-7a-hydroxylase activity and on serum and hepatic cholesterol levels in the rat. Internat J Vit Nutr Res 61: 364–369, 1991Google Scholar
  20. 20.
    Hulcher FH, Oleson WH: A simplified spectrophotometric assay for microsomal HMG-CoA reductase by measurement of CoA. Lipid Res 14: 625–631, 1973Google Scholar
  21. 21.
    Hartree EF: A modification of the Lowry's method that gives a linear photometric response. Anal Biochem 48: 422–427, 1972Google Scholar
  22. 22.
    Snedecor GW, Cochran WG: Statistical Methods-6th Edn., Iowa State University Press, Ames, USA: 1976, p 298Google Scholar
  23. 23.
    Sosenko JM, Breskiw JL, Miettinen OS, Gabby KH: Hyperglycemia and plasma lipids — A prospective study of young insulin dependent diabetic patients. N Eng J Med 302: 650–654, 1980Google Scholar
  24. 24.
    Sekhar N, Govindaswamy S: Effects of vanadate on plasma lipoprotein profiles in experimental diabetic rat. Biochem Internat 23: 935–940, 1991Google Scholar
  25. 25.
    Suresh Babu P, Srinivasan K: Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat. Mol Cell Biochem 152: 13–21, 1995Google Scholar
  26. 26.
    Maechler P, Wollheim CB, Bentzen CL, Niesor E: Role of the intestinal acyl-CoA: cholesterol acyltransferase activity in the hyperresponse of diabetic rats to dietary cholesterol. J Lip Res 33: 1475–1484, 1992Google Scholar
  27. 27.
    Laakso M, Sarlund H, Mykkanen L: Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Atherosclerosis 10: 223–231, 1990Google Scholar
  28. 28.
    Taskinen MR: Quantitative and qualitative lipoprotein abnormalities in Diabetes 41: 12–17, 1992Google Scholar
  29. 29.
    Akira E: The discovery and development of HMG CoA reductase inhibitors. J Lip Res 33: 1569–1582, 1992Google Scholar
  30. 30.
    Grundy SM, Bilheimer DW: Inhibition of 3-HMG CoA reductase by mevinolin in familial hypercholesterolemia-heterozygotes: Effect of cholesterol balance. Proc Natl Acad Sci 81: 2538–2542, 1984Google Scholar
  31. 31.
    Garg A, Grundy SM: Lovastatin for lowering cholesterol levels in NIDDM. New Eng J Med 318: 81–86, 1988Google Scholar
  32. 32.
    Hommel E, Andersen P, Gall MA et al.: Plasma lipoprotein and renal function during simvastatin treatment in diabetic nephropathy. Diabetologia 35: 447–451, 1992Google Scholar
  33. 33.
    Mayes PA: Cholesterol synthesis, transport and excretion. In Harpers Biochemistry, 22nd Edition, 1990, pp 249–260Google Scholar
  34. 34.
    Fears R: Cholesterol-7a-hydroxylase In: R Fears and JR Sabine (eds). CRC Press, Boca Raton, 1986, pp 116–132Google Scholar
  35. 35.
    Ganesh Bhat B, Srinivasan MR, Chandrasckhara N: Influence of curcumin and capsaicin on the composition and secretion of bile in rats. J Fd Sci Technol 21: 225–227, 1984Google Scholar
  36. 36.
    Danielsson H, Sjovall J: Bile acid metabolism. Ann Rev Biochem 44: 233–253, 1975Google Scholar
  37. 37.
    Gustafsson BE, Angelin B, Erinarsson K, Gustafsson JA: Influence of cholestyramine on synthesis of cholesterol and bile acids in germfree rats. J Lipid Res 19: 972–977, 1978Google Scholar
  38. 38.
    Shepherd J, Packard CJ, Bicken S et al.: Cholestyramine promotes receptor mediated LDL catabolism. New Eng J Med 302: 1219–1222, 1980Google Scholar
  39. 39.
    Kovanen PT, Bitheimer DW, Goldstein JL et al.: Regulatory role of hepatic LDL receptors in vivo in dogs. Proc Natl Acad Sci 78: 1194–1198, 1981Google Scholar
  40. 40.
    Reaven EP, Reaven GM: Mechanisms for development of diabetic hypertriglyceridemia in streotozotocin treated rats. J Clin Invest 54: 1167–1178, 1974Google Scholar
  41. 41.
    Vantol A: Hypertriglyceridemia in diabetic rat, defective removal of serum VLDL. Atherosclerosis, 26: 117–128, 1977Google Scholar
  42. 42.
    Begadade JD, Porte D Jr, Biorman EL: Acute insulin withdrawal and the regulation of plasma triglyceride removal in diabetic subjects. Diabetes 17: 127–132, 1968Google Scholar
  43. 43.
    Srinivasan MR, Satyanarayana MN: Influence of capsaicin, curcumin and ferulic acid in rats fed high fat fed diets. J Biosci 12: 143–152, 1987Google Scholar
  44. 44.
    Rajalingam R, Srinivasan N, Govindarajulu P: Effects of alloxan induced diabetes on lipid profiles in renal cortex and medulla of mature albino rats. Indian J Exp Biol 31: 577–579, 1993Google Scholar

Copyright information

© Kluwer Academic Publishers 1997

Authors and Affiliations

  • P. Suresh Babu
    • 1
  • K. Srinivasan
    • 1
  1. 1.Department of Biochemistry and NutritionCentral Food Technological Research InstituteMysore-India

Personalised recommendations